{
    "Trade/Device Name(s)": [
        "IMDx Flu A/B and RSV for Abbott m2000"
    ],
    "Submitter Information": "Intelligent Medical Devices, Inc.",
    "510(k) Number": "K131584",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103209"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "001"
    ],
    "Summary Letter Date": "May 29, 2013",
    "Summary Letter Received Date": "May 31, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A",
        "Influenza B",
        "RSV A",
        "RSV B"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Viral transport medium"
    ],
    "Instrument(s)/Platform(s)": [
        "Abbott m2000 System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time reverse transcription polymerase chain reaction (RT-PCR)",
        "Automated nucleic acid extraction",
        "Fluorogenic target-specific hybridization"
    ],
    "Methodologies": [
        "RT-PCR",
        "Multiplex nucleic acid testing"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for IMDx Flu A/B and RSV for Abbott m2000, a multiplex real-time RT-PCR assay for detection of influenza A, influenza B, and RSV RNA from nasopharyngeal swabs.",
    "Indications for Use Summary": "Qualitative in vitro assay performed on the Abbott m2000 System for the detection of influenza A, influenza B, and RSV RNA directly from nasopharyngeal swabs from patients with respiratory infection symptoms; intended as an aid in diagnosing influenza A, B, and/or RSV infection.",
    "fda_folder": "Microbiology"
}